A detailed history of Alera Investment Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Alera Investment Advisors, LLC holds 10,517 shares of AZN stock, worth $697,277. This represents 0.1% of its overall portfolio holdings.

Number of Shares
10,517
Previous 11,232 6.37%
Holding current value
$697,277
Previous $875,000 6.4%
% of portfolio
0.1%
Previous 0.11%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$76.67 - $87.62 $54,819 - $62,648
-715 Reduced 6.37%
10,517 $819,000
Q2 2024

Aug 13, 2024

SELL
$66.81 - $80.83 $203,970 - $246,773
-3,053 Reduced 21.37%
11,232 $875,000
Q1 2024

May 10, 2024

SELL
$61.03 - $69.57 $19,468 - $22,192
-319 Reduced 2.18%
14,285 $967,000
Q4 2023

Jan 23, 2024

SELL
$61.89 - $69.28 $9,964 - $11,154
-161 Reduced 1.09%
14,604 $983,000
Q3 2023

Oct 11, 2023

SELL
$64.85 - $71.7 $1,426 - $1,577
-22 Reduced 0.15%
14,765 $999,000
Q2 2023

Jul 26, 2023

SELL
$69.91 - $75.81 $978 - $1,061
-14 Reduced 0.09%
14,787 $1.06 Million
Q1 2023

May 01, 2023

BUY
$63.15 - $71.6 $508,610 - $576,666
8,054 Added 119.37%
14,801 $1.03 Million
Q4 2022

Feb 02, 2023

BUY
$54.21 - $70.44 $3,306 - $4,296
61 Added 0.91%
6,747 $457,000
Q3 2022

Nov 09, 2022

SELL
$53.02 - $135.75 $7,687 - $19,683
-145 Reduced 2.12%
6,686 $367,000
Q2 2022

Aug 08, 2022

BUY
$59.26 - $71.14 $108,445 - $130,186
1,830 Added 36.59%
6,831 $452,000
Q1 2022

May 10, 2022

BUY
$55.72 - $67.12 $278,655 - $335,667
5,001 New
5,001 $332,000
Q2 2019

Aug 07, 2019

SELL
$37.28 - $41.68 $21,175 - $23,674
-568 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$35.49 - $43.02 $8,056 - $9,765
-227 Reduced 28.55%
568 $23,000
Q4 2018

Feb 14, 2019

BUY
$36.86 - $41.49 $29,303 - $32,984
795 New
795 $30,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Alera Investment Advisors, LLC Portfolio

Follow Alera Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alera Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alera Investment Advisors, LLC with notifications on news.